234. Dalbavancin versus Outpatient Parenteral Antimicrobial Therapy with Vancomycin for Treatment of Bone and Joint Infections in a Veteran Population

BACKGROUND: Dalbavancin is a long-acting lipoglycopeptide with broad gram-positive activity. A long half-life makes it an attractive treatment option for bone and joint infections (BJI). Previous studies have demonstrated efficacy of dalbavancin in the treatment of BJI. Based on these studies, our i...

Descripción completa

Detalles Bibliográficos
Autores principales: Gibbons, Emily A, Hopkins, Teri L, Escobar, Manuel R, Yang, Linda, Walter, Elizabeth, Cadena-Zuluaga, Jose
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2021
Materias:
Poster Abstracts
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8644410/
http://dx.doi.org/10.1093/ofid/ofab466.436

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8644410/
http://dx.doi.org/10.1093/ofid/ofab466.436

Ejemplares similares